Dataset from A Phase 3/4, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Adult Subjects of Black Race With Systemic Lupus Erythematosus (SLE)

The purpose of this study is to evaluate the efficacy, safety, and tolerability of belimumab
in adult patients of black race with systemic lupus erythematosus (SLE; lupus).

本研究旨在评估贝利尤单抗（belimumab）在黑人成年系统性红斑狼疮（systemic lupus erythematosus，SLE，又称狼疮）患者中的疗效、安全性与耐受性。